Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Bromperidol Decanoate

    ACTIVE PHARMA INGREDIENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 75067-66-2, 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl decanoate, 73lg72m4lv, R-46541, Decanoic acid,4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl ester, Bromperidol decanoate (usan)
    Molecular Formula
    C31H41BrFNO3
    Molecular Weight
    574.6  g/mol
    InChI Key
    ZINCPWWBSRSXBH-UHFFFAOYSA-N
    FDA UNII
    73LG72M4LV
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate
    2.1.2 InChI
    InChI=1S/C31H41BrFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3
    2.1.3 InChI Key
    ZINCPWWBSRSXBH-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Br
    2.2 Other Identifiers
    2.2.1 UNII
    73LG72M4LV
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Decanoate

    2. Impromen Decanoas

    2.3.2 Depositor-Supplied Synonyms

    1. 75067-66-2

    2. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl Decanoate

    3. 73lg72m4lv

    4. R-46541

    5. Decanoic Acid,4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl Ester

    6. Bromperidol Decanoate (usan)

    7. R-46,541

    8. Bromperidol Decanoate [usan]

    9. Decanoic Acid, 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Ester

    10. Unii-73lg72m4lv

    11. Bromperidoldecanoat

    12. Bromperidol Decanoate [usan:ban]

    13. Einecs 278-065-1

    14. [4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] Decanoate

    15. Bromoperidol Decanoate

    16. R 46541

    17. Schembl121019

    18. Chembl2106135

    19. Dtxsid30226039

    20. Bromperidol Decanoate [mart.]

    21. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Decanoate

    22. Bromperidol Decanoate [usp-rs]

    23. Bromperidol Decanoate [who-dd]

    24. 4-(4-(p-bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone Decanoate (ester)

    25. Bromperidol Decanoate [ep Impurity]

    26. Bromperidol Decanoate [ep Monograph]

    27. D02626

    28. R 46,541

    29. Q27266190

    30. 4-(4-(p-bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone Decanoate

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 574.6 g/mol
    Molecular Formula C31H41BrFNO3
    XLogP37.9
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count16
    Exact Mass573.22538 g/mol
    Monoisotopic Mass573.22538 g/mol
    Topological Polar Surface Area46.6 Ų
    Heavy Atom Count37
    Formal Charge0
    Complexity665
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antipsychotic Agents

    Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)